The therapeutic roles of etanercept and thalidomide in bleomycin induced experimental scleroderma

Basit Öğe Kaydı
dc.contributor.authorIsik, A.
dc.contributor.authorKoca, S.
dc.contributor.authorEvren, B.
dc.contributor.authorUstundag, B.
dc.contributor.authorOzercan, I.
dc.contributor.authorMetin, K.
dc.date.accessioned2026-08-12T18:12:44Z
dc.date.issued2007
dc.departmentFırat Üniversitesi
dc.descriptionAnnual European Congress of Rheumatology (EULAR 2007) -- JUN 13-16, 2007 -- Barcelona, SPAIN
dc.description.abstract[Abstract Not Available]
dc.description.sponsorshipEuropean League Against Rheumatism
dc.identifier.endpage213
dc.identifier.issn0003-4967
dc.identifier.startpage212
dc.identifier.urihttps://hdl.handle.net/11508/64023
dc.identifier.volume66
dc.identifier.wosWOS:000253101100674
dc.identifier.wosqualityQ1
dc.indekslendigikaynakWeb of Science
dc.language.isoen
dc.publisherB M J Publishing Group
dc.relation.ispartofAnnals of the Rheumatic Diseases
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20260511
dc.subjectNecrosis-Factor-Alpha
dc.titleThe therapeutic roles of etanercept and thalidomide in bleomycin induced experimental scleroderma
dc.typeConference Object

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu